High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.

Catherine Patte(Institut Gustave Roussy), F Pein, D Dufillot, C Rodary(Institut Gustave Roussy), J P Lamagnère, Thierry Philip(Institut Curie), H. Behrendt, J.C. Gentet, J M Zucker, Jacques Otten

Journal of Clinical Oncology

January 1, 1991

10.1200/jco.1991.9.1.123

Cited by 296

Related Papers

Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge

|Journal of Clinical Oncology|2015|450

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

|Blood|2006|431

SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease

|Neuro-Oncology|2013|371

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

|Blood|2006|362

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

|New England Journal of Medicine|2020|308